Genomic analysis drives tailored therapy in poor risk childhood leukemia
- PMID: 22897843
- DOI: 10.1016/j.ccr.2012.07.012
Genomic analysis drives tailored therapy in poor risk childhood leukemia
Abstract
Ph-like acute lymphoblastic leukemia (ALL) is a novel subgroup of high-risk childhood ALL. In this issue of Cancer Cell, Roberts et al. describe the identification of genetic alterations that lead to activated kinase and cytokine receptor signaling in Ph-like ALL and demonstrate that this aberrant signaling can be inhibited effectively.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.Cancer Cell. 2012 Aug 14;22(2):153-66. doi: 10.1016/j.ccr.2012.06.005. Cancer Cell. 2012. PMID: 22897847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
